Moleculin Biotech
MBRX
MBRX
29 hedge funds and large institutions have $3.71M invested in Moleculin Biotech in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+8
Holders Change %
+38.1%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
5
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PWMG
26
Prestige Wealth Management Group
Flemington,
New Jersey
| $1K | – | – | – |
|
|
PFO
27
Pathstone Family Office
Englewood,
New Jersey
| $1K | +$1K | +11 | New |
|
28
Barclays
London,
United Kingdom
| $1K | +$1K | +13 | New |
|
|
TSS
29
Two Sigma Securities
New York
| – | -$55K | -1,001 | Closed |
|
|
RJFSA
30
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$44K | -806 | Closed |
|
31
Citadel Advisors
Miami,
Florida
| – | -$22K | -400 | Closed |
|
32
Victory Capital Management
San Antonio,
Texas
| – | -$10K | -167 | Closed |
|
|
PFGIA
33
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| – | -$2K | -28 | Closed |
|